|3.||Eating Disorders (Eating Disorder)
|4.||Body Weight (Weight, Body)
|5.||Opportunistic Infections (Opportunistic Infection)
|1.||Hong, Chen-Jee: 6 articles (12/2011 - 09/2002)|
|2.||Tsai, Shih-Jen: 6 articles (12/2011 - 09/2002)|
|3.||Ghatule, R R: 3 articles (10/2013 - 02/2013)|
|4.||Marcus, Ronald: 3 articles (10/2013 - 11/2008)|
|5.||Goel, R K: 3 articles (10/2013 - 02/2013)|
|6.||Gautam, M K: 3 articles (10/2013 - 02/2013)|
|7.||Singh, A: 3 articles (10/2013 - 02/2013)|
|8.||Liou, Ying-Jay: 3 articles (12/2011 - 10/2005)|
|9.||Wang, Ying-Chieh: 3 articles (06/2010 - 01/2004)|
|10.||Lin, Ching-Hua: 3 articles (01/2004 - 09/2002)|
|1.||Insulin (Novolin)FDA Link
01/01/2013 - "Importantly, MLDL1278a treatment improved insulin sensitivity independent of body weight change. "
05/01/2015 - "Hypoglycaemia prevalence was <20% in years 1-4. Body weight change was mostly in year 1, and was very variable, mean +2.7 (7.5)kg at year 4. Different insulin regimens were started in people with differing characteristics, and they evolved differently; insulin dose, hypoglycaemia and body weight change were diverse and largely independent of regimen."
12/01/2013 - "Comparing insulin regimens between individuals matched by propensity scores indicated differences in hypoglycaemia and body weight change, despite similar HbA1c reductions. "
01/01/2012 - "Insulin-stimulated cerebrocortical theta activity at baseline correlated with a reduction in total adipose tissue (r = -0.59, p = 0.014) and visceral adipose tissue (r = -0.76, p = 0.001) after 9 months of lifestyle intervention, accompanied by a statistical trend for reduction in body weight change (r = -0.37, p = 0.069). "
05/15/2009 - "i.c.v. infusion of Foxo1-ASO reduced the cumulative food intake (21%), body weight change (28%), epididymal fat pad weight (22%) and fasting serum insulin levels (19%) and increased the insulin sensitivity (34%) in DIO but not in control animals. "
|2.||Glucose (Dextrose)FDA LinkGeneric
07/21/2015 - "Here, we report that genetic and induced models of hypothalamic ER stress are associated with alterations in systemic glucose homeostasis due to increased gluconeogenesis (GNG) independent of body weight changes. "
08/01/2014 - "However, if the body weight changes significantly, as in a long experiment, quantification based on the glucose corrected percentage injected dose (and not SUV) is recommendable as this yields the lowest intra-animal variation. "
04/01/2013 - "The parameters evaluated were behavioral changes, body weight, serum glucose level, lipid profile and oxidative stress. "
04/01/2013 - "Effect of treatments on body weight change and plasma glucose levels were not significant. "
11/01/2012 - "Frequent adverse side effects include disturbances of lipid and glucose metabolism, body weight changes and alterations of the QTc interval. "
|3.||Alanine Transaminase (SGPT)IBA
03/01/2000 - "In addition, body weight change was lowered and serum glutamic pyruvic transaminase activity was elevated significantly compared to control at 24 h after the treatment, suggesting induction of systemic and hepatic toxicity respectively. "
01/01/2014 - "Meanwhile, anti-CD40-BFL elicited unapparent body-weight changes and a significant reduction in serum levels of tumor necrosis factor-α, interleukin-1β, interleukin-6, interferon-γ, and hepatic enzyme alanine transaminase, suggesting minimized systemic side effects. "
03/01/2000 - "Body weight change, serum glutamic pyruvic transaminase (SGPT) activity, serum urea nitrogen (SUN) concentration, liver and kidney weights, and renal lipid peroxide level could not be affected significantly in mice at 4 h after intraperitoneal administration of DL-lactic acid at 1.2 mmol/kg, indicating no induction of toxicity in the liver and kidney. "
03/01/2014 - "Although treatment of diabetic rats with oral administration of carvacrol resulted in a slight reduction in serum glucose level and significant reduction in serum total cholesterol, alanine aminotransferase, aspartate aminotransferase and lactate dehydrogenase in comparison with diabetic control rats, there were no significant differences in serum insulin levels, food-water intake values and body weight changes. "
10/01/1998 - "Effects of uranyl acetate on food and water consumption, body weight changes; plasma urea nitrogen (BUN), creatinine concentrations and activities of alkaline phosphatase (ALP), aspartate aminotransferase (AST) and alanine aminotransferase (ALT) were assayed by time-course experiment. "
01/01/2013 - "A significantly greater decrease in fat mass loss was observed in the calcium + D group (-2.8±1.3 vs.-1.8±1.3 kg; P=0.02) than in the control group, although there was no significant difference in body weight change (P>0.05) between groups. "
11/01/1986 - "This correlation was independent of age, basal blood pressure, serum calcium concentration, basal 24-hour urinary sodium excretion, and body weight changes during the trial. "
05/01/2002 - "The aim of this study is to determine the effects of 1,25(OH)2D3 and its analogues on tumor growth and body weight, changes in plasma ionized calcium, parathyroid hormone-related protein (PTHrP) production, bone resorption, and the distribution of the 1,25(OH)2D3 receptor (VDR) on tumors in nude mice-bearing the canine adenocarcinoma (CAC-8). "
09/01/2011 - "White tea extract consumption did not significantly change body weight gain, food intake, food efficiency, protein efficiency ratio, apparent protein digestibility, nitrogen balance, or the apparent absorption of calcium, phosphorus, magnesium, and zinc. "
10/01/1988 - "Aflatoxicosis in this study was characterized by a significant (P less than .05) reduction in body weight, changes in red blood cell counts and serum levels of protein, albumin, glucose, cholesterol, and calcium, and magnesium, activity of the serum enzymes lactic dehydrogenase and alkaline phosphatase, and a significant (P less than .05) increase in relative weights of the liver, kidney, spleen, pancreas, proventriculus, and heart. "
|5.||Blood Glucose (Blood Sugar)IBA
07/01/2009 - "However, SbE, a very strong antioxidant extract, administered at 5-50 mg/kg (based on our previous studies without adverse events) for 12 days did not show any significant effects on blood glucose and body weight changes. "
04/01/1988 - "Blood glucose and body weight changes were monitored throughout the study. "
10/01/2014 - "Body weight change was analysed every third week as was blood glucose and various lipid parameters. "
05/15/2012 - "The blood glucose level, daily urinary volume and body weight changes were measured. "
07/01/2011 - "The MEAV has beneficial effects in reducing the elevated blood glucose level and body weight changes, and improves the lipid profile of STZ induced rats."
05/01/2003 - "A decrease in serum cholesterol levels was observed in the group, which was fed a diet containing CS-OT or CS for 1-2 weeks, but no differences in body weight changes were recognized. "
01/01/1991 - "Serum cholesterol and body weight change did not respond significantly to the fescue challenge. "
04/01/1984 - "In the second experiment, the possible relationship between level of feed intake, body weight change and yolk cholesterol was further investigated. "
04/01/1984 - "In addition, yolk cholesterol was positively correlated with body weight change (r = 0.23, P less than 0.01). "
02/01/2000 - "Body weight change during the study period, more than initial body weight, was found to have influenced the rise in serum cholesterol. "
12/17/2003 - "In the present study, using DFI and body weight change (BWC) as indicators, we took a further step to examine whether repeated co-administrations of D1 and D2 agonists might produce an AMPH-like action. "
03/01/2011 - "A retrospective chart review of 100 consecutive patients was performed to examine the effects of co-morbidities and body weight changes in the immediate preoperative period on the hospital length of stay and the rate of admission to the surgical intensive care unit (SICU). "
02/15/2010 - "In conclusion, body weight changes in patients with morbid obesity were associated with changes in LV structure independent of improvement in obesity-related co-morbidities, including obstructive sleep apnea. "
08/01/2000 - "The aim was to co-relate the reproductive organ and body-weight changes with changes in the serum hormone levels following the administration of the ester. "
03/20/2007 - "To determine the potential influence of hexane co-exposure on butadiene toxicity, the present study examined the effect of n-hexane on butenediol disposition [as measured by urinary excretion of (N-acetyl-S-(3,4-dihydroxybutyl)-L-cysteine) (MI level)] and genotoxicity (as measured by the frequency of bone marrow micronucleated erythrocytes) and acute toxicity (as measured by body weight changes) in the rat. "
01/01/2015 - "Tear osmolarity alteration induced by HD is correlated with body weight changes, creatinine alterations, and ultrafiltration. "
01/01/1991 - "Indices used to evaluate toxicity included body weight changes, BUN and serum creatinine levels and the histopathological examination of renal tissue. "
01/01/1993 - "The change of ANF levels was positively correlated with the body weight change and creatinine change after HD."
01/01/1991 - "The differences in the effectiveness of the procedures were assessed using BUN and serum creatinine values, histopathological examination, body weight changes, and renal platinum levels as indices. "
05/01/2013 - "The serum levels of blood urea nitrogen (BUN) and creatinine (Cr), kidney tissue damage score (KTDS), and kidney weight (KW) and body weight changes in CDDP-treated groups increased significantly (P < 0.05). "
|9.||Glucagon-Like Peptide 1 (GLP 1)IBA
11/01/2014 - "In clinical studies, GLP-1 RA have demonstrated a significant lowering of blood pressure that is independent of body weight changes. "
10/01/2014 - "We decided to analyze the effects of the rs6923761 GLP-1 R polymorphism on body weight changes and metabolic parameters after 3 months of a hypocaloric diet. "
03/01/2012 - "An HFD reverses the improvement in glucose tolerance induced by DJB surgery in T2DM rats, primarily ascribing to the re-impairment of insulin sensitivity, but does not change body weight, GLP-1 and PYY levels."
09/01/2008 - "To this aim, an intraperitoneal or intracerebroventricular injection of exendin (9 - 39), a GLP-1 antagonist, (50 or 10 microg per rat, respectively) followed by leptin (100 or 5 microg per rat, respectively) was made and 24-hour food intake and body weight changes were measured. "
11/01/2011 - "The rats were followed for 6 weeks after surgery, and their body weight change, cumulative food intake, metabolic parameters, plasma levels of ghrelin, glucagon-like peptide-1 and adiponectin, oral glucose tolerance test (OGTT), insulin tolerance test (ITT), and gastric emptying rate were measured. "
|10.||Metformin (Glucophage)FDA LinkGeneric
10/01/2005 - "The addition of metformin is also beneficial in terms of body weight changes. "
01/01/2001 - "Biochemical and body weight changes with metformin in polycystic ovary syndrome."
08/01/2009 - "Body weight changes were -0.45+/-0.20 kg in vildagliptin-treated patients (p=0.02) and -1.25+/-0.19 kg in metformin-treated patients (p<0.001; p=0.004 vs. vildagliptin). "
12/01/1997 - "Slight body weight changes were observed with acarbose (-0.8 kg) and metformin (-0.5 kg), but not with placebo. "
02/01/2014 - "To study the incidence of hypoglycemia, glycemic control and body weight changes in patients with type 2 diabetes treated with vildagliptin and metformin versus another group treated with sulphonylureas and metformin during and after the period of fasting in Ramadan. "
06/03/2013 - "Signs of toxicity, body weight changes, relative organs weight, feed and water consumption were monitored following 28 days of daily oral administration of graded doses of the extract in rats. "
11/01/2012 - "The parameters evaluated daily after oral drug administration of the extract (540, 1080, 2160 and 3240 mg/kg body weight) were mortality, signs of toxicity, feed and water consumption and body weight changes up to 14 days. "
05/01/2009 - "After oral administration of SD-2007 (0, 0.2, 1, 5 or 25 mg/mouse), the clinical signs, mortalities, body weight changes, blood biochemical parameters, absolute and relative organ weights were examined. "
04/01/1976 - "Effects of oral administration of 0, 5, 10, or 20 mug of 6 alpha, 9 alpha-difluoro-16alpha-methyl-prednisolone (Flumethasone) daily on milk and milk component yields, udder health reproductive performance, and body weight change were measured. "
08/01/2015 - "Pharmacokinetics of TFT was determined in nude mice after single oral administration of TAS-102, while the antitumor activity and body weight change were evaluated in the tumor-bearing nude mice after multiple oral administrations for 2 weeks. "
02/01/2013 - "There were no abnormal findings in the external appearance, and body weight change after treatment with CSE for 5 weeks. "
05/01/1998 - "Body weight change, dietary intake, eating behaviors, and barriers to adherence were measured at baseline and after treatment. "
10/20/1995 - "Body weight change of aNPY-injected animals was significantly lower than controls, and the effect was reversed after treatments ceased. "
01/01/2014 - "Finally, in patients with hyperthyroidism a significant reduction of zinc-α2-glycoprotein serum levels was detected after treatment but was unrelated to body weight changes. "
03/01/1987 - "After treatment there was no difference in body weight change between the group treated with NCS in lactate and the group treated with NCS in PBS. "
01/01/2015 - "This controlled, clinical trial with a two-year intervention was aimed at comparing the efficacy of two nonsurgical approaches versus bariatric surgery, on body weight changes and metabolic parameters in morbidly obese patients. "
06/01/2013 - "The mechanism by which bariatric surgery results in body weight changes is incompletely elucidated, but it clearly goes beyond caloric restriction and malabsorption. "
|5.||Renal Dialysis (Hemodialysis)
01/01/2015 - "Retrospective study of 2002-2010 adult incident hemodialysis to analyze the relationship between body mass index (BMI) and annual body weight changes with mortality in different age strata. "
07/01/2007 - "Body weight changes significantly reduced from 57.57+/-6.78 kg to 55.26+/-9.92 kg (p<0.001) after the hemodialysis. "
01/01/1996 - "In this study we investigated the interactions between volume changes (body weight), plasma atrial natriuretic peptide (pANP) and ambulatory blood pressure (BP) in 10 patients with end-stage renal disease undergoing regular hemodialysis (HD) treatment three times weekly. "
04/01/2002 - "Hemodialysis (HD) patients have a high percentage of complications, such as vascular diseases, and they are subject to hyperkinetic blood flows and abrupt body weight changes secondary to HD, which can invalidate BP recording. "
09/01/1994 - "Balance measurement of changes in a patient's body weight during hemodialysis has a significant methodological error made by patient's body weight changes unassociated with ultrafiltration."